|
FY2025
12 months to Dec 31, 2025
|
FY2024
11 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Interest earned on marketable securities held in Trust Account | ||
| Unrealized gain on marketable securities held in Trust Account | ||
| Payment of formation costs through promissory note | ||
| Payment of operating costs through promissory note | ||
| Dividends and interest earned on marketable securities held in Trust Account | ||
| Unrealized loss on investments held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accounts payable and accrued expenses | ||
| Advances from related parties | ||
| Due to Sponsor | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placements Warrants | ||
| Repayment of promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Non-cash investing and financing activities: | ||
| Offering costs charged to additional paid in capital | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | ||
| Deferred offering costs paid through promissory note - related party | ||
| Prepaid expenses paid by Sponsor | ||
| Deferred underwriting fee payable | ||
| Offering costs charged to shareholders’ deficit |
Loading...
